Share this
Introducing Cooley’s Life Sciences & Healthcare Innovation Hub – A New Resource for Life Sciences and Healthcare Companies
Firm also plans to reprise successful Life Sciences and Healthcare Innovation Program in January 2022 • December 9, 2021
Stori Closes One of Latin America’s Largest Series C Rounds
November 30, 2021
Cooley Named Corporate Firm of the Year at LMG Life Sciences Awards
September 24, 2021
Life Sciences Companies Are 'Voracious' Consumers of Capital, Driving $500M in Annual Revenue at Cooley
The Recorder • September 9, 2021
Legal 500 US 2021 Highlights Cooley
July 19, 2021
Morning Consult Reaches Unicorn Status With Series B Round
June 9, 2021
Cooley Tops PitchBook VC Charts for US Deals + Company-Side Representation Globally
Firm earns #1 spots across multiple categories in latest rankings • June 3, 2021
Chicago-Based Amount Hits Billion-Dollar Valuation With Series D Round
June 1, 2021
Pie Insurance Raises $118 Million Series C
April 9, 2021
PitchBook Confirms Cooley’s Emerging Companies and Venture Capital Leadership
Cooley represents more venture-backed companies than any firm in the US and globally, according to latest Global League Tables • March 2, 2021
New Leadership for Cooley Life Sciences
Longtime head Barbara Kosacz retires from partnership, remains senior counsel • July 17, 2020
If Your Firm Has a Life Sciences Practice, It's Probably Very Busy Right Now
The Recorder • April 20, 2020
CARES Act: What You Need to Know
Cooley Alert • March 29, 2020
Autolus – $173 Million IPO
July 9, 2018
Sucampo Sells to Mallinckrodt for $1.2 Billion
December 27, 2017
Sucampo Acquires Vtesse
April 12, 2017
Cavion – $26 Million Series A Financing
January 19, 2017
Prasco Acquires Rights to Authorized Generic of Adderall XR®
October 17, 2016
Senseonics Holdings, Inc. – $49 Million IPO
April 13, 2016
Cardioxyl Sells to Bristol-Myers Squibb for up to $2 Billion
November 5, 2015
Scioderm Sells to Amicus Therapeutics for up to $947 Million
October 2, 2015
Cooley Advises on First US IPO of 2014 for GlycoMimetics
January 23, 2014
Cooley Represents Micromet in $1.2 Billion Sale to Amgen (Reuters and Bloomberg BusinessWeek)
January 26, 2012
Cooley Advises Micromet on $1.16 Billion Sale to Amgen
Healthcare Reform Law Will Provide Cash Grants and Tax Credits for Qualifying Life Sciences Companies
Cooley Alert • March 31, 2010